Publications & Works

Articles 251
All (251)
SCI-E, SSCI, AHCI (198)
SCI-E, SSCI, AHCI, ESCI (228)
ESCI (24)
Scopus (228)
TRDizin (51)
Other Publications (8)

47. EDITORIAL

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.34, no.1, 2023 (SCI-Expanded, Scopus, TRDizin)
Papers Presented at Peer-Reviewed Scientific Conferences 113

4. POSTPARTUM HİPOPİTUİTARİZM: GEÇ TANI KONULAN BİR SHEEHAN SENDROMU OLGUSU

Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme-2025, Turkey, 10 - 13 April 2025, pp.0-48, (Summary Text)

11. Otoimmün Tanılı Hastalarda Viral Serolojik Profilin Değerlendirilmesi

7. Ulusak Klinik Mikrobiyoloji Kongresi (KLİMUD), Muğla, Turkey, 1 - 05 November 2023, pp.635, (Summary Text)

13. HYPERLIPIDEMIA, ATHEROSCLEROSIS AND HEPATOSTEATOSIS IN PRIMARY BILIARY CHOLANGITIS: WHAT IS THE RISK?

Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 10 - 14 November 2023, (Summary Text)

14. Tenofovir resistance-associated mutations at patients with chronic hepatitis B

ESCV 2023 - 25th Annual Meeting of the European Society for Clinical Virology., Milan, Italy, 30 August - 02 September 2023, pp.141-142, (Full Text) Sustainable Development

15. ARE THERE NEW PRACTICAL MARKERS TO PREDICT MALIGNANCY IN PANCREATIC CYST FLUIDS?

Digestive Disease Week 2023, Washington, United States Of America, 6 - 09 May 2023, pp.774, (Summary Text)

17. Real-world data of tenofovir alafenamide in treatment-naive and experienced patients with Chronic Hepatitis B: more efficacy, less side effects

39. Ulusal Gastroenteroloji Haftası ve 10. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 22 - 27 November 2022, pp.1159-1162, (Summary Text)

21. İshal ve kilo kaybının nadir bir nedeni:Amiloidoz

21. Çapa Gastroenteroloji Günleri, İstanbul, Turkey, 31 March - 02 April 2022, pp.70, (Full Text)

22. Girişimsel Gastroenterolojik İşlemlerde Hastaların Doktor Tercihinde Cinsiyet Önemli mi?

38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 16 - 21 November 2021, pp.204, (Full Text)

24. Budd-Chiari Sendromu’nda Hepatoselüler Kanser ve Mortalitenin Değerlendirilmesi

38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 16 - 21 November 2021, pp.219, (Summary Text) Sustainable Development

26. THE MORPHOMETRIC ASSESSMENT OF HEPATIC ARTERY AND BILE DUCT ON LIVER NEEDLE BIOPSY IN PRIMARY SCLEROSING CHOLANGITIS

Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 13 - 16 November 2020, vol.72, (Summary Text)

27. TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B: WHAT ARE THE TRIGGERS OF DRUG-RELATED ADVERSE EFFECTS?

Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 13 - 16 November 2020, vol.72, (Summary Text) Sustainable Development

28. Bariyatrik by-pass cerrahisi sonrası uzun dönemde geğirti artıyor mu?

7. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 29 November - 01 December 2019, pp.99, (Summary Text)

29. Diyabet ve pankreas enzim yetersizliği ilişkisi

36. Ulusal Gastroenteroloji Mezuniyet Sonrası Eğitim Toplantısı ve 7. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 29 November 2019, (Full Text)

31. Is belching increasing after bariatric by-pass surgery in the long term period?

United European Gastroenterology (UEG) Week 2019, Spain, 19 - 23 October 2019, vol.7, pp.703, (Summary Text)

33. EUS GUIDED GASTROJEJUNOSTOMY (GEJ) - IS IT READY FOR PRIME TIME?: A SYSTEMATIC REVIEW AND META-ANALYSIS

Digestive Disease Week (DDW), California, United States Of America, 18 - 21 May 2019, vol.89, (Summary Text)

35. Türkiye Yaşlılarda Uygunsuz İlaç Kullanım Kriterleri - TIME Kriterleri

2. Uluslararası ve 12. Akademik Geriatri Kongresi, Antalya, Turkey, 24 - 28 April 2019, (Summary Text)

36. TURKISH INAPPROPRIATE MEDICATION USE IN THE ELDERLY (TIME) CRITERIA

2.INTERNATIONAL AND 12. ACADEMIC GERIATRICS CONGRESS, Antalya, Turkey, 24 - 28 April 2019, (Full Text)

37. Turkısh Inappropriate Medication Use in the Elderly (TIME) Criteria

2. Uluslararası ve 12. Akademik Geriatri Kongresi, Antalya, Turkey, 24 - 28 April 2019, (Summary Text)

38. Hepatosellüler Karsinomda Ga-PSMA PET/BT’nin Rolü

31. ULUSAL NÜKLEER TIP KONGRESİ, Antalya, Turkey, 10 - 14 April 2019, vol.1, pp.21, (Summary Text)

42. Is It Sufficient Only to Request an Anti-HCV Test for the Performance of HCV Screening?

Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Costa Rica, 9 - 13 November 2018, vol.68, (Summary Text)

43. Clinical Impact of Endosonography in the Differantial Diagnosis of Indeterminate Biliary Strictures

Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Costa Rica, 9 - 13 November 2018, vol.68, (Summary Text)

44. Is there any predictor for relapse after treatment withdrawal in autoimmune hepatitis patients in the real life?

68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Washington, Kiribati, 20 - 24 October 2017, vol.66, (Summary Text) Sustainable Development

45. Tens asitli siroz hastalarında intraabdominal hipertansiyonun prognoz üzerine etkisi

11. Ulusal Hepatoloji Kongresi, Antalya, Turkey, 17 - 21 May 2017, pp.31-32, (Summary Text)

46. Vitamin D receptor gene polymophhism may affect the interferon response in chronic hepatitis B patients

The 26th Conference of Asian Pacific Association for the Study of the Liver APASL Annual Meeting 2017, Şangay, China, 15 - 19 February 2017, pp.1, (Full Text) Sustainable Development

51. Olgu sunumu: İmmünokompetan hastada dissemine tüberküloz lenfadenopatisi

32. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 25 - 29 November 2015, pp.94, (Full Text) Sustainable Development

52. Olgu sunumu: İmmünokompetan hastada dissemine tüberküloz lenfadenopatisi

32. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 25 - 29 November 2015, vol.26, pp.94, (Summary Text)

53. Nedeni bilinmeyen aşikar gastrointestinal (GİS) kanamalarda kapsül deneyimimiz

10. Ulusal Travma ve Acil Cerrahi Kongresi, Antalya, Turkey, 28 October - 01 November 2015, pp.25, (Summary Text) Creative Commons License Sustainable Development

54. The role of cytokines and adhesion molecules in hepatocellular carcinoma to predict survival

66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Costa Rica, 13 - 17 November 2015, vol.62, (Summary Text)

56. Belching in irritable bowel syndrome: an impedance study

NeuroGASTRO Conference, İstanbul, Turkey, 4 - 06 June 2015, pp.38-39, (Summary Text)

57. Analysis of Hepatitis C Virus NS5A Region in Cirrhotic Patients Using an Ultra Deep Pyrosequencing Method

Istanbul University, World Conference on Technology, Innavation and Entrepreneurship, İstanbul, Turkey, 28 - 30 May 2015, pp.1, (Full Text) Sustainable Development

59. Chronic Renal Failure after Liver Transplantation in Long Term: Prevalence and Risk Factors.

Joint International Congress of ILTS, ELITA and LICAGE, London, Canada, 4 - 07 June 2014, vol.20, (Summary Text)

60. SMALL BOWEL MUCOSAL FINDINGS IN FAMILIAL MEDITERRANEAN FEVER

15th Annual European Congress of Rheumatology (EULAR), Paris, France, 11 - 14 June 2014, pp.307, (Summary Text)

61. ENTECAVIR AND TENOFOVIR HAVE A COMPARABLE EFFICACY IN TREATMENT OF NUCLEOS(T)IDE ANALOGUE NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A REAL LIFE EXPERIENCE

49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, London, Canada, 9 - 13 April 2014, (Summary Text)

62. Baseline alfa-fetoprotein level is a strong predictor of vascular invasion and survival in patients with hepatocellular carcinoma

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013, vol.58, (Summary Text)

63. Risk factors for significant liver fibrosis in genotype D HBeAg-negative chronic hepatitis B infection with persistently normal ALT and high serum HBVDNA levels

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013, (Summary Text) Sustainable Development

64. Tenofovir disoproxil fumarate has a substantial efficacy against adefovir and multi-drug resistant strains of hepatitis B virus

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013, (Summary Text) Sustainable Development

65. The antiviral efficacy of entecavir is not influenced by prior treatment with nucleos(t)ide analogues in patients with chronic hepatitis B

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013, (Summary Text)

66. Virological Supression Does not Prevent the Development of Hepatocellular Carsinoma in Cirrhotic Patients with Genotype D Hepatitis B Infection

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013, vol.58, (Summary Text) Sustainable Development

67. Safety of Tenofovir in Renal Transplanted and Hemodialysis Patients with Chronic Hepatitis B

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013, vol.58, (Summary Text) Sustainable Development

68. IL28B Polymorphisms and Influence on Sustained Virological Response to Interferon Therapy in Chronic DELTA Hepatitis.

Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Orlando, United States Of America, 18 - 21 May 2013, vol.144, no.5, (Full Text) Sustainable Development

69. Acil üst gis endoskopi ile farkedilen ampüller nöroendokrin karsinom

11. Ulusal Endoskopik Laparoskopik Cerrahi Kongresi, Muğla, Turkey, 2 - 06 October 2013, vol.20, no.1, pp.144, (Full Text)

70. IL28B Polymorphisms and Influence on Sustained Virological Response to Interferon Therapy in Chronic DELTA Hepatitis

Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Florida, United States Of America, 18 - 21 May 2013, vol.144, (Summary Text) Sustainable Development

71. Does Chemoprophylaxis Prevent Tuberculosis Reactivation in the Long Term Period of Anti-TNF Treatment?

Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Florida, United States Of America, 18 - 21 May 2013, vol.144, (Summary Text)

72. Zor gastrointestinal kanamalarda kapsül endoskopisinin yeri

9. Ulusal Travma ve Acil Cerrahi Kongresi, İstanbul, Turkey, 19 - 23 April 2013

73. Zor gastrointestinal kanamalarda kapsül endoskopinin yeri

9. Ulusal Travma ve Acil Cerrahi Kongresi, Antalya, Turkey, 19 - 23 April 2013, pp.36, (Summary Text) Creative Commons License

74. TREATMENT FAILURE MAY LEAD TO ACCELERATED FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C

International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, Netherlands, 24 - 28 April 2013, (Summary Text)

76. Number connection test-A and inhibitor control test are not efficient for diagnosis of minimal hepatic encephalopathy in cirrhotic patients

63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 9 - 13 November 2012, vol.56, (Summary Text)

77. Response to tenofovir treatment of treatment-naive and adefovir experienced patients with chronic hepatitis b

63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 9 - 13 November 2012, vol.56, (Summary Text) Sustainable Development

78. EVALUATION OF MICA, HLA-DRB1 AND HLA-DQB1 GENOTYPES IN PATIENTS WITH ULCERATIVE COLITIS

Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference, Liverpool, United Kingdom, 31 May - 03 June 2012, vol.79, pp.577, (Summary Text)

80. Success of Two Different Endoscopic Submucosal Resection Methods in Gastric Subepithelial Lesions

Digestive Disease Week (DDW), California, United States Of America, 19 - 22 May 2012, vol.75, pp.136, (Summary Text)

83. ANTIVIRAL RESISTANCE IN NAIVE GENOTYPE D CHRONIC HEPATITIS B PATIENTS BY ULTRA-DEEP PYROSEQUENCING

62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Costa Rica, 4 - 08 November 2011, vol.54, (Summary Text) Sustainable Development

84. ENDOSONOGRAFİK OLARAK STROMAL TÜMÖRÜ TAKLİT EDEN MİDENİN METASTATİK TÜMÖRÜ

27. ULUSAL GASTROENTEROLOJİ HAFTASI, Antalya, Turkey, 24 - 28 November 2010, pp.253, (Full Text)

85. PRECORE/CORE PROMOTER MUTATIONS BY ULTRA-DEEP PYROSEQUENCING IN GENOTYPE D CHRONIC HEPATITIS B NAIVE PATIENTS

45th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Viyana, Austria, 14 April 2010 - 18 April 2014, pp.238, (Full Text) Sustainable Development

86. Does Cholecystectomy Increase the Esophageal Alkaline Reflux? Evaluation by Impedance-pH Technique

Digestive Disease Week/111th Annual Meeting of the American-Gastroenterological-Association, Louisiana, United States Of America, 1 - 06 May 2010, vol.71, (Summary Text)

87. PRECORE/CORE PROMOTER MUTATIONS BY ULTRA-DEEP PYROSEQUENCING IN GENOTYPE D CHRONIC HEPATITIS B NAIVE PATIENTS

45th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Vienna, Austria, 14 - 18 April 2010, (Summary Text)

91. What is the cause of iron overload in HBV related chronic liver disease

British Society of Gastrenterology Annual General Meeting, Glasgow, United Kingdom, 23 - 26 March 2009, pp.1955, (Full Text)

92. HBsAg CLEARENCE AFTER LONG-TERM FOLLOW-UP IN CHRONIC HEPATITIS B PATIENTS TREATED WITH INTERFERON ALPHA AND NUCLEOS(T)IDE ANALOGUES

44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Copenhagen, Denmark, 22 - 26 April 2009, (Summary Text)

94. Influence of ghrelin on gastric accommodation and meal-induced satiety in man

Digestive Disease Week Meeting/109th Annual Meeting of the American-Gastroenterological-Association, California, United States Of America, 17 - 22 May 2008, vol.134, (Summary Text)

95. The presence of HCVRNA in the peripheral blood mononuclear cells of the individuals with isolated anti HCV positivity: Is HCV hiding out?

43rd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Milan, Italy, 23 - 27 April 2008, (Summary Text) Sustainable Development

96. Influence of NK-1 receptor antagonist-aprepitant on rectal sensitivity and compliance in healty volunteers

Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 May 2007, vol.132, (Summary Text)

97. A new agent for tumour necrosis factor-alpha inhibition: In vitro effects of dipyridamole in Crohn's disease

Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 May 2007, vol.132, (Summary Text)

98. Influence of itopride and domperidone on gastric tone and on the perception of gastric distention in healthy subjects

Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 May 2007, vol.132, (Summary Text)

100. Influence of naloxone on meal-related symptoms and gastric emptying rate in man

Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 May 2007, vol.132

101. Role of mucosal nerve endings in acid-induced duodenogastric sensorimotor reflexes in man

Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 May 2007, vol.132, (Summary Text)

102. Are esophageal manometry and pH-metry necessary before fundoplication?

Digestive Disease Week/107th Annual Meeting of the American-Gastroenterological-Association, Los-Angeles, Chile, 19 - 24 May 2006, vol.130, (Summary Text)

103. Intestinal metaplasia in portal hypertensive gastropathy: Is it a part of natural course

Digestive Disease Week Meeting/107th Annual Meeting of the American-Gastroenterlogical-Association, Los-Angeles, Chile, 20 - 25 May 2006, vol.130, (Summary Text)

104. Virological breakthrough is not a detrimental phenomenon in patients with compensated cirrhosis:: Results of a long term lamivudine therapy

56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Costa Rica, 11 - 15 November 2005, (Summary Text)

105. Hepatosteatosis in patients with chronic hepatitis B:: Prevalence and the effect on the treatment response rate to α-interferon

40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Paris, France, 13 - 17 April 2005, pp.241-242, (Summary Text)

107. The effects of roziglitazone, metformine and diet with exercise in nonalcoholic fatty liver disease

39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Berlin, Germany, 14 - 18 April 2004, pp.167, (Summary Text)

108. Combined or monotherapy, which is better in AntiHBe (+) chronic hepatitis B ?

Digestive Disease Week 2003 Meeting/104th Annual Meeting of the American-Gastroenterological-Association, ORLANDO, FLORIDA, 17 - 22 May 2003, vol.124, (Summary Text)

109. Long term results of alpha-interferon monotherapy

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Turkey, 29 March - 01 April 2003, pp.149, (Summary Text)

110. Autoimmune hepatitis; What factors predict the response to combination therapy of azathioprine plus steroid

Digestive Disease Week 2003 Meeting/104th Annual Meeting of the American-Gastroenterological-Association, ORLANDO, FLORIDA, 17 - 22 May 2003, vol.124, (Summary Text) Sustainable Development

111. Efficacy of alpha interferon therapy for lamivudine resistance in chronic hepatitis B

53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), BOSTON, MASSACHUSETTS, 1 - 05 November 2002, (Summary Text)

112. Occult HBV infection and YMDD mutants in hemodialysis patients with chronic HCV infection.

53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), BOSTON, MASSACHUSETTS, 1 - 05 November 2002, (Summary Text)

113. The preliminary results of interferon alpha and ribavirin combination therapy in chronic delta hepatitis.

53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), BOSTON, MASSACHUSETTS, 1 - 05 November 2002, (Summary Text)
Metrics

Publication

366

Publication (WoS)

285

Publication (Scopus)

228

Citation (WoS)

2551

H-Index (WoS)

24

Citation (Scopus)

2947

H-Index (Scopus)

27

Citation (Scholar)

323

H-Index (Scholar)

8

Citation (TrDizin)

10

H-Index (TrDizin)

2

Citation (Sum Other)

10

Project

11

Thesis Advisory

17

Open Access

28
UN Sustainable Development Goals